2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 32697348 | Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients. | 2020 Nov | 1 |
| 2 | 20035824 | Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts. | 2010 Mar | 1 |